{"title":"[Carumonam].","authors":"A. Saito","doi":"10.32388/55zue3","DOIUrl":null,"url":null,"abstract":"An N-sulfo monocyclic beta-lactam antibiotic derived from sulfazecin. Carumonam has high resistance to beta-lactamases and activity against aerobic gram-negative bacteria. It reaches high urinary concentrations and may be used in the treatment of urinary tract infections.","PeriodicalId":22536,"journal":{"name":"The Japanese journal of antibiotics","volume":"10 1","pages":"613-22"},"PeriodicalIF":0.0000,"publicationDate":"2020-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Japanese journal of antibiotics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32388/55zue3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
An N-sulfo monocyclic beta-lactam antibiotic derived from sulfazecin. Carumonam has high resistance to beta-lactamases and activity against aerobic gram-negative bacteria. It reaches high urinary concentrations and may be used in the treatment of urinary tract infections.